The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mchale Duncan since 2022.
This trader's CIK number is 1738896.
At the time of last reporting, Mchale Duncan was the Chief Medical Officer of Evelo Biosciences, Inc.. (stock ticker symbol EVLO).
Also see all insider trading activities at Evelo Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | EVLO | 0 | $0 | 80,121 | $44,348 | 155,500 | $0 |
| 2022 | EVLO | 34,246 | $49,999 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-08 | EVLO | Sale | 3,103 | .33 | 1,023 |
| 2023-11-07 | EVLO | Option Ex | 6,500 | .00 | 0 |
| 2023-11-02 | EVLO | Sale | 6,854 | .33 | 2,261 |
| 2023-11-01 | EVLO | Option Ex | 12,500 | .00 | 0 |
| 2023-08-08 | EVLO | Sale | 3,434 | 9.51 | 32,657 |
| 2023-08-07 | EVLO | Option Ex | 6,500 | .00 | 0 |
| 2023-05-08 | EVLO | Sale | 66,730 | .13 | 8,407 |
| 2023-05-07 | EVLO | Option Ex | 130,000 | .00 | 0 |
| 2022-05-27 | EVLO | Buy | 34,246 | 1.46 | 49,999 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mchale Duncan (Chief Medical Officer of Evelo Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.